SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-005518
Filing Date
2023-08-10
Accepted
2023-08-10 17:03:16
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sunshine_i10q-063023.htm   iXBRL 10-Q 811259
2 CERTIFICATION sunshine_ex3101.htm EX-31.1 13440
3 CERTIFICATION sunshine_ex3102.htm EX-31.2 13691
4 CERTIFICATION sunshine_ex3201.htm EX-32.1 5904
5 GRAPHIC sunshinelogo.jpg GRAPHIC 6215
6 GRAPHIC adva-27a.jpg GRAPHIC 12912
  Complete submission text file 0001683168-23-005518.txt   3700033

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE sbfm-20230630.xsd EX-101.SCH 30424
8 XBRL CALCULATION FILE sbfm-20230630_cal.xml EX-101.CAL 46526
9 XBRL DEFINITION FILE sbfm-20230630_def.xml EX-101.DEF 137660
10 XBRL LABEL FILE sbfm-20230630_lab.xml EX-101.LAB 226058
11 XBRL PRESENTATION FILE sbfm-20230630_pre.xml EX-101.PRE 203743
53 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10q-063023_htm.xml XML 385636
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41282 | Film No.: 231160513
SIC: 2834 Pharmaceutical Preparations